Fogorvosi szemle, 2017 (110. évfolyam, 1-4. szám)

2017-03-01 / 1. szám

29

FOGORVOSI SZEMLE ■ 110. évf. 1. sz. 2017.

logic correlation with contemporary review of prognostic iondicators. Int J Surg Pathol. 2012; 20: 37-46.

9. Krengli M, Masini L, Kaanders JH, Maingon P, Oei SB, Zouhair A, et al.: Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A rare cancer network study. Int J Radiat Oncol Biol Phys 2006; 65: 751-759.

10. Lu S-Y, Lin C-F, Shun-Chen H: Metastatic oral malignant melanoma transformed from pre-existing pigmented lesions in mandibular gingiva: Report of an unusual case. J Dent Sei., 2013, 8: 328-332

11. Main BG, Coyle MJ, Godden A, Godden DR: The metastatic potenciál of head and neck cutaneous malignant melanom: is sentinel biopsy useful?, B J Oral Maxi/lofacSurg. 2014; 52: 340-343.

12. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busám K, Kageshita T étal.: Determinants of BRAFmutations in primary melanomas. J Natl Cancer Inst. 2003; 95:1878-1890.

13. Maldonado-Mendoza J, Ramirez-Amador V, Anaya-Saavedra G, Irigoyen-Camacho M, Ruiz-Godoy EL, Ruiz-Garcia E et al.: Clinicopathological characterization of primary oral and sinonasal melanoma in a referral centre in Mexico City: 2000-2012. Int J Oral Maxillofac Surg. 2015; 44: 427-432.

14. McLean N .Tighiouart M, Muller S: Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol 2008; 44: 1039-1046.

15. Meleti M, Leemans CR, Mooi WJ, Vescovi P, van der Waal I: Oral malignant melanoma: A review of the literature, Oral Oncol. 2007; 43: 116- 121.

16. Mohan M, Sukhadia VY, Pai D, Bhat S: Oral malignant melanoma: systemic review of literature and report of two cases, Int J Oral Maxillofac Surg. 2013; 116: 247-254.

17. Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M. et al: Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from M. D. Anderson Cancer Center. Cancer 2010; 116: 2215-2223.

18. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ et al: Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Cancer Network 2013; 11 : 917-923.

19. Postow MA, Hamid O, Carvajal RD: Mucosal melanoma: pathogenezis, clinical behaviour and management. Curr Oncol Rep 2012; 14: 441-448.

20. Postow MA, Luke JJ, Bluth MJ, Ramaiya N, Panageas KS, Lawrence DP et al: Ipilimumab for patients with advanced mucosal melanoma. Oncologist 2013; 18: 726-732.

21. Prasad ML, Patel SG, Huvos AG, Shah JP, Busám KJ: Primarymucosal melanoma of the head and neck: a proposal formicrostaging localized, stage I (lymph node-negative) tumors. Cancer 2004; 100:1657-64.

22. Rivera RS, Nagatsuka H, Gunduz M, Cengiz B, Gunduz E: C-KIT protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma. Virchows Arch. 2008; 452: 27-32.

23. Starek I, Koranda P, Benes P: Sentinel lymph node biopsy: a new perspective in head and neck mucosal melanoma? Melanoma Res 2006; 16: 423-427.

24. Tanaka N, Amagasa T, Iwaki H, Shioda S, Takeda M, Ohasi K et al: Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol. 1994; 78: 81.

25. Tanaka N, Mimura M, Ogi K, Amagasa T: Primary malignant melanoma of the oral cavity: assessment of outcome from the clinical records of 35 patients. Int J Oral Maxillofac Surg. 2004; 33: 761-765.

26. Temam S, Mamelle G, Marandas P, Wibault P, Avril MF, Janót F et al: Postoperative radiotherapy for primary mucosal melanoma of the head and neck Cancer, 2005; 103: 313-319.

27. Umeda M, Shimada K: Primary malignant melanoma of the oral cavity - its histological classification and treatment, B J Oral Maxillofac Surg. 1994; 32: 39-47.

28. Wang X, Wu, Ren GX, Tang J, Guo W: Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically NO patient. J Oral Maxillofac Surg. 2012; 70: 1192-1198.

29. Wu Y, Zhong Y, LiC, Song H, Guo W, Ren G: Neck dissection for oral mucosal melanoma: Caution of nodular lesion. Oral Oncol. 2014; 50: 319-324.

30. Yi JH, Yi SY, Lee HR, Lee SI, Lim DH, Kim JH et al: Dacarbazinebased chemotherapy asfirst-line treatment in noncutaneous metastatic melanoma: multicenter, retrospective analysis in Asia. Melanoma Res. 2011 ; 21: 223-227.

31. Yunteng W, Yi Z, Chaojun L, Hao S, Wei G, Guoxin R: Neck dissection for oral mucosal melanoma: Caution of nodular lesion. Oral Oncol. 2014; 50: 319-324.

Kiss F, Fülôp G, Oberna F, Battyáni Z

Head and neck mucosal melanoma; clinicopathological analysis of 5 cases and review of the literature

Mucosal melanoma in the region of head and neck is a rare and aggressive tumor. Diagnosis is usually late due to the quick, vertical spread of the disease, the a lack of early or specific signs and because of the location of lesions. The mainstay of treatment is radical surgical resection. The value of sentinel lymph node biopsy, lymphadenectomy and radiotherapy is still unclear. The objective of this study is to report five patients with primer malignant mucosal melanoma and briefly summarize the current literature of the etiology, staging and treatment of the disease.

Keywords: head and neck, mucosal melanoma, diagnosis, staging, radical surgical resection